Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
Researchers investigated the impact of pre-transplant liver fibrosis on outcomes in patients with sickle cell disease undergoing hematopoietic stem cell transplantation.
A specialized inpatient sickle cell disease (SCD) consult service led to improved pain management, shorter hospital stays and expanded use of individualized pain plans for patients with SCD.
A nationwide analysis reveals that patients with sickle cell disease (SCD) hospitalized for opioid overdose have comparable in-hospital mortality rates to patients without SCD, but exhibit better discharge...